NCT00000821View on ClinicalTrials.gov

Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

78

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 2002

Conditions

HIV Infections

Interventions

DRUG

Aldesleukin

Trial Locations (1)

20892

Natl Inst of Allergy & Infect Dis / Cln Ctr, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH